Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease

Background/Aims: Anti-drug antibodies (ADAs) can develop during treatment with anti-tumor necrosis factor (TNF) agents. We aimed to investigate the factors associated with immunogenicity of anti-TNF agents in pediatric patients with inflammatory bowel disease (IBD) and observe the clinical course of...

Full description

Bibliographic Details
Published in:Gut and Liver
Main Authors: Ju Young Kim, Yoon Lee, Byung-Ho Choe, Ben Kang
Format: Article
Language:English
Published: Gastroenterology Council for Gut and Liver 2021-07-01
Subjects:
infliximab
adalimumab
crohn disease
ulcerative colitis
children
Online Access:http://gutnliver.org/journal/view.html?doi=10.5009/gnl20134

Internet

http://gutnliver.org/journal/view.html?doi=10.5009/gnl20134

Similar Items